Lifecore Biomedical LFCR
NASDAQ LFCR
$6.37 +0.01 (+0.16%)
At close: Nov 9, 2026 · 4:00 PM EST

Lifecore Biomedical (LFCR) Gains (Losses) on Sale of Assets & Investments (2022 - 2023)

Updated

Lifecore Biomedical (LFCR) reported Non Operating Investment Income of -$300,000 for fiscal Q4 2023 (quarter ended May 28, 2023), compared with -$336,000 a year earlier.

Analysis

Lifecore Biomedical (LFCR) Gains (Losses) on Sale of Assets & Investments (2022 - 2023) Analysis & Trends

For FY2023 (ended May 28, 2023), Lifecore Biomedical posted Non Operating Investment Income of -$18.87 million.

  • By fiscal year, Non Operating Investment Income came in at -$336,000 in FY2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
May 28, 2023 -300,000.00
Aug 28, 2022 2.11 Mn
May 29, 2022 -336,000.00
API Access

Lifecore Biomedical Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LFCR&period=max&api_key=YOUR_API_KEY